http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015200594-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 |
| filingDate | 2015-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e201ea9e8b2963d21cdbe499ed84e66d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12f54402b66621acbe183c5d70bd9ea8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1d4af99aa5432aa5c4be8802be55a03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d66059caa231bbb0f3976a0b06d6067 |
| publicationDate | 2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2015200594-A1 |
| titleOfInvention | Novel glucagon analogues |
| abstract | The present invention relates to novel peptide compounds which have an improved physical stability in solution and improved solubility at neutral pH, to the use of the 5 compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of hyperglycemia, diabetes and obesity, as well as a variety of diseases or conditions associated with hyperglycemia, diabetes and obesity. |
| priorityDate | 2010-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 655.